Diabetes, Type 2 Clinical Trial
Official title:
Technologically Enhanced Community Health Worker (CHW) Delivery of Personalized Diabetes Information
Two of AHRQ 's consumer-focused guides, "Pills for Type 2 Diabetes" and "Premixed Insulin
for Type 2 Diabetes" could be of great use to underserved ethnic and racial minority adults.
The presentation of content and delivery mechanisms of these Guides, however, needs to be
modified to increase their use and impact among these difficult-to-reach populations.
To achieve this goal, a long-standing collaboration among African American and Latino
community organizations, health care centers and systems, public health organizations, and
academics (the REACH Detroit Partnership) is joining with leading experts in the development
of personally and culturally tailored health decision aids (University of Michigan's Center
for Health Communications Research [CHCR] and Center for Behavioral and Decision Sciences in
Medicine [CBDSM]).
The investigators will develop and evaluate a computer tailored online diabetes medication
decision aid that will enable community health workers (CHWs) to provide personalized
patient education materials to underserved diabetic African American and Latino adults in
Detroit, Michigan.
The Specific Aims of this study are:
Aim 1: To use the information in the two diabetes medications consumer CERSGs to build an
interactive, computer tailored diabetes medication guide that will enable patients to assess
their treatment goals, personal preferences, and side-effect concerns and generate a
personally tailored assessment of their current diabetes treatments with, as appropriate,
options for improving their diabetes care;
Aim 2: To determine the extent to which this personally tailored diabetes medication guide
compared with the print consumer guides reduces Latino and African American diabetes
patients' decisional conflict, through improved knowledge of anti-hyperglycemic medications
and satisfaction with information received.
Aim 3: To examine the computer tailored program's effects on participants' changes in
medications (medication intensification), self-reported medication adherence and beliefs and
A1C levels between baseline and follow-up compared to participants receiving the print
consumer guides.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01805414 -
Breakfast Nutrition and Inpatient Glycemia
|
N/A | |
| Completed |
NCT02648685 -
The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM
|
||
| Completed |
NCT00141232 -
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03397225 -
A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control
|
N/A | |
| Completed |
NCT01837680 -
Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
|
N/A | |
| Completed |
NCT01336738 -
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT00308737 -
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00246987 -
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
|
Phase 3 | |
| Completed |
NCT01193179 -
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00857558 -
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 2 | |
| Terminated |
NCT01350102 -
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
|
Phase 4 | |
| Completed |
NCT01624116 -
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
|
N/A | |
| Completed |
NCT01634282 -
Along-term Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 3 | |
| Withdrawn |
NCT02222623 -
The Inova Type 2 Diabetes Mellitus Study
|
N/A | |
| Recruiting |
NCT06340854 -
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
|
Phase 3 |